바로가기 메뉴
메인메뉴 바로가기
본문내용 바로가기
  • HOME
  • 로그인
  • 회원가입
  • 세명기독병원 홈페이지 바로가기
홈버튼 Home > 약제과 소식 > 최신 의학 정보

최신 의학 정보

최신약물정보 (FDA 승인 약물 2013.12-2014.2)

게시일 2014-03-18 09:16
Anoro Ellipta (umeclidinium and vilanterol inhalation powder); GlaxoSmithKline; For the maintenance treatment of chronic obstructive pulmonary disease, Approved December of 2013
Sovaldi (sofosbuvir); Gilead Sciences; For the treatment of hepatitis C, December of 2013
Xiaflex (collagenase clostridium histolyticum); Auxilium; For the treatment of Peyronie's disease, Approved December of 2013
Tretten (Coagulation Factor XIII A-Subunit [Recombinant]); Novo Nordisk; For the treatment of congenital factor XIII (FXIII) A-subunit deficiency, Approved December of 2013
Farxiga (dapagliflozin); Bristol-Myers Squibb; For the treatment of type II diabetes, January of 2014
Myalept (metreleptin for injection); Bristol-Myers Squibb; For the treatment of congenital or acquired generalized lipodystrophy, Approved February of 2014
Northera (droxidopa); Chelsea Therapeutics; For the treatment of neurogenic orthostatic hypotension, Approved February 2014
Tivorbex (indomethacin); Iroko Pharmaceuticals; For the treatment of acute pain, Approved February of 2014
Vimizim (elosulfase alfa); BioMarin; For the treatment of Mucopolysaccharidosis type IVA, Approved February 2014
Imbruvica (ibrutinib); Pharmacyclics; For the treatment of chronic lymphocytic leukemia, Approved February 2014
Hetlioz (tasimelteon); Vanda Pharmaceuticals; For the treatment of non-24-hour sleep-wake disorder in the totally blind, January 2014
코멘트 0|조회 1,238
게시물 내용 인쇄하기인쇄| 최희영
  • 목록
  • 쓰기
댓글달기
이름   인증비번   자동확인방지 자동방지키

문서평가/문서담당자

[37816] 경북 포항시 남구 포스코대로 351 (대도동 94-5) 세명기독병원 대표전화 054-275-0005

copyright 2014 semyung gidok hospital. all rights reserved